Seeking Alpha

Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and...

Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M) of its previously authorized repurchase program during Q2; CEO Michael Mussallem will purchase $5M worth of shares tomorrow at either Wednesday's closing price or the average closing price for the 10 trading days ending Monday, whichever is higher; CFO Thomas Abate will retire this year. Despite a 5-day, ~5% rally, the shares are still reeling from April 24th's post-earnings dive and subsequent downgrades.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|